Nima Farzan, Director of Keros Therapeutics KROS, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $28.2K. The latest trade was on 06/04.

NF

NF

Nima Farzan

Director

Company

Keros Therapeutics KROS

First filing

23/02/14

Trades

15 trades

Buys / sales

0 / 1

12-month net buying

−$28.2K

Last trade

06/04

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Keros TherapeuticsKROS	Open-market sale10b5-1 plan	06/04	06/08	2,625 sh	$10.73	$28,166.25	−21.2%